"10.1371_journal.pone.0018865","plos one","2011-04-21T00:00:00Z","Idris Guessous; Olivier Bonny; Fred Paccaud; Vincent Mooser; GÃ©rard Waeber; Peter Vollenweider; Murielle Bochud","Community Prevention Unit, Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland; Unit of Population Epidemiology, Division of Primary Care Medicine, Department of Community Medicine, Primary Care and Emergency Medicine, Geneva University Hospitals, Geneva, Switzerland; Service of Nephrology and Hypertension, Lausanne University Hospital and Department of Pharmacology and Toxicology, University of Lausanne, Lausanne, Switzerland; Genetics Division, GlaxoSmithKline Research and Development, King of Prussia, Pennsylvania, United States of America; Department of Medicine, Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland","Conceived and designed the experiments: IG MB OB GW PV FP VM. Performed the experiments: IG MB OB. Analyzed the data: IG MB. Contributed reagents/materials/analysis tools: IG. Wrote the paper: IG MB OB VM.","VM is a full-time employee of GSK and the CoLaus study was sponsored in part by GlaxoSmithKline. There are no patents, products in development or marketed products to declare. MB is an Academic Editor for PLoS ONE. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2011","04","Idris Guessous","IG",7,TRUE,7,3,2,4,TRUE,TRUE,FALSE,0,NA,FALSE
